Reserpine Substantially Lowers Blood Pressure in Patients with Refractory Hypertension: A Proof of Concept Study.

CONCLUSIONS: Reserpine, a potent sympatholytic agent, lowers BP in patients whose BP remained uncontrolled on maximal antihypertensive therapy, lending support to the hypothesis that excess sympathetic output contributes importantly to the development of RfHTN. PMID: 32179903 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32179903?dopt=Abstract

Source: American Journal of Hypertension - March 16, 2020 Category: Cardiology Authors: Siddiqui M, Bhatt H, Judd EK, Oparil S, Calhoun DA Tags: Am J Hypertens Source Type: research